Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism

被引:86
作者
Cortes, D [1 ]
Thorup, J
Visfeldt, J
机构
[1] Rigshosp, Dept Pediat Surg, DK-2100 Copenhagen, Denmark
[2] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark
关键词
testis; cryptorchidism; gonadotropin releasing hormone; gonadotropins; chorionic;
D O I
10.1016/S0022-5347(05)67763-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Hormonal treatment with human chorionic gonadotropin (HCG) or gonadotropin releasing hormone may be given initially for cryptorchidism. We evaluated whether hormonal treatment is safe for the germ cells in boys with cryptorchidism 1 to 3 years old in whom follicle-stimulating hormone, luteinizing hormone and testosterone values are normally low. Materials and Methods: We measured the number of spermatogonia per tubule at orchiopexy in 72 consecutive boys with cryptorchidism who underwent simultaneous testicular biopsy. In 19 patients gonadotropin releasing hormone was unsuccessful, while 8 received HCG and 45 underwent orchiopexy without hormonal therapy. Groups were otherwise equal. Results: Patients who underwent surgery only had a higher number of spermatogonia per tubule than those in whom hormonal treatment was unsuccessful (p <0.05). Spermatogonia per tubule values were normal only after surgery alone (p = 0.06). Gonadotropin releasing hormone and HCG influenced germ cells equally. Conclusions: In 1 to 3-year-old boys with cryptorchidism gonadotropin releasing hormone or HCG given for testicular descent may suppress the number of germ cells.
引用
收藏
页码:1290 / 1292
页数:3
相关论文
共 20 条
[1]   Longitudinal reproductive hormone profiles in infants:: Peak of inhibin B levels in infant boys exceeds levels in adult men [J].
Andersson, AM ;
Toppari, J ;
Haavisto, AM ;
Petersen, JH ;
Simell, T ;
Simell, O ;
Skakkebæk, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :675-681
[2]   Serum inhibin B in healthy pubertal and adolescent boys:: Relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels [J].
Andersson, AM ;
Juul, A ;
Petersen, JH ;
Müller, J ;
Groome, NP ;
Skakkebæk, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :3976-3981
[3]   BUSERELIN TREATMENT OF CRYPTORCHIDISM - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
BICA, DTG ;
HADZISELIMOVIC, F .
JOURNAL OF UROLOGY, 1992, 148 (02) :617-621
[4]   Cryptorchidism: medical and surgical treatment in the 1st year of life [J].
Canavese, F ;
Cortese, MG ;
Magro, P ;
Lonati, L ;
Teruzzi, E ;
de Sanctis, C ;
Lala, R .
PEDIATRIC SURGERY INTERNATIONAL, 1998, 14 (1-2) :2-5
[5]  
Cortes D, 1998, Scand J Urol Nephrol Suppl, V196, P1
[6]   Fertility potential after unilateral orchiopexy: Simultaneous testicular biopsy and orchiopexy in a cohort of 87 patients [J].
Cortes, D ;
Thorup, JM ;
Lindenberg, S .
JOURNAL OF UROLOGY, 1996, 155 (03) :1061-1065
[7]   KINETICS OF THE STEROIDOGENIC RESPONSE TO SINGLE VERSUS REPEATED DOSES OF HUMAN CHORIONIC-GONADOTROPIN IN BOYS IN PREPUBERTY AND EARLY PUBERTY [J].
DUNKEL, L ;
PERHEENTUPA, J ;
APTER, D .
PEDIATRIC RESEARCH, 1985, 19 (01) :1-4
[8]   Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult [J].
Dunkel, L ;
Taskinen, S ;
Hovatta, O ;
Tilly, JL ;
Wikstrom, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2341-2346
[9]   RESULTS OF EARLY TREATMENT OF CRYPTORCHIDISM WITH HUMAN CHORIONIC-GONADOTROPIN [J].
GARAGORRI, JM ;
JOB, JC ;
CANLORBE, P ;
CHAUSSAIN, JL .
JOURNAL OF PEDIATRICS, 1982, 101 (06) :923-927
[10]   MATURATION OF THE NORMAL PITUITARY-TESTICULAR AXIS, AS ASSESSED BY GONADOTROPIN-RELEASING-HORMONE AGONIST CHALLENGE [J].
GHAI, K ;
ROSENFIELD, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1336-1340